{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:49:15Z","timestamp":1790639355804,"version":"4.1.0"},"reference-count":36,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Malignant pleural effusion is a common and distressing complication of advanced cancer, often resulting in severe symptoms such as dyspnoea, which significantly impacts patients\u2019 quality of life. This study evaluates the effectiveness and safety of talc slurry pleurodesis as a palliative treatment for recurrent malignant pleural effusion and examines predictive factors for pleurodesis success and survival. Methods: A single-centre cohort study was conducted at the Thoracic Surgery Department of the University Clinical Centre of Kosovo between April 2022 and March 2024. The study included adult patients with recurrent and symptomatic malignant pleural effusion who met specific inclusion criteria for performing pleurodesis. Patients were followed prospectively with routine clinical evaluations until the conclusion of the study on 9 September 2024. Descriptive and inferential statistics were employed to evaluate the success of pleurodesis and its associated outcomes. Results: The study shows a success rate of 84.6% at 30 days post-procedure, with 57.6% achieving complete success and 42.4% partial success. Talc slurry pleurodesis was associated with minimal complications, with chest pain and fever being the most common adverse effects. The most significant predictors of survival post-pleurodesis identified were the Karnofsky Performance Status score and serum neutrophil-to-lymphocyte ratio. Patients with higher Karnofsky Performance Status scores and lower neutrophil-to-lymphocyte ratios had improved survival outcomes. Conclusions: This study suggests that talc slurry pleurodesis is an effective and safe option for managing malignant pleural effusions in patients with low-performance status, offering symptom relief and potentially extending survival in certain patients. Further research is required to refine predictive models for treatment success.<\/jats:p>","DOI":"10.3390\/jcm14217527","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:34:45Z","timestamp":1761273285000},"page":"7527","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness and Safety of Talc Slurry Pleurodesis in the Treatment of Patients with Malignant Pleural Effusion and Low Karnofsky Performance Status Scores"],"prefix":"10.3390","volume":"14","author":[{"given":"Eliza","family":"Kastrati","sequence":"first","affiliation":[{"name":"Chest Department, University Clinical Centre of Kosovo, 10000 Prishtina, Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1088-3404","authenticated-orcid":false,"given":"Antigona","family":"Hasani","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Faculty of Medicine, University of Hasan Prishtina, 10000 Prishtina, Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadil","family":"Gradica","sequence":"additional","affiliation":[{"name":"University City Hospital of Tirana \u201cShefqet Ndroqi\u201d, 1044 Tirana, Albania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tefta","family":"Isufaj Haliti","sequence":"additional","affiliation":[{"name":"Clinic of Obstetrics and Gynaecology, University Clinical Centre of Kosovo, 10000 Prishtina, Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidana","family":"Bolat","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Group, 10000 Prishtina, Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-1406","authenticated-orcid":false,"given":"Ilir","family":"Hoxha","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Group, 10000 Prishtina, Kosovo"},{"name":"The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH 03766, USA"},{"name":"Department of Health Management, Heimerer College, 10000 Prishtina, Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1183\/09031936.00165607","article-title":"Pleural drainage and pleurodesis: Implementation of guidelines in four hospitals","volume":"32","author":"Burgers","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.15761\/ICST.1000144","article-title":"Pleurodesis in malignant pleural effusions: Outcome and predictors of success","volume":"2","author":"Rafei","year":"2015","journal-title":"Integr. Cancer Sci. Therap."},{"key":"ref_3","first-page":"266","article-title":"Predictors of talc slurry pleurodesis success in patients with malignant pleural effusion","volume":"23","author":"Santosa","year":"2017","journal-title":"Pulmonology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejcdt.2015.05.003","article-title":"Pleural fluid CRP, LDH, and pH as predictors of successful pleurodesis in malignant pleural effusions","volume":"64","author":"Shehata","year":"2015","journal-title":"Egypt. J. Chest Dis. Tuberc."},{"key":"ref_5","first-page":"5071","article-title":"Talc Pleurodesis as Surgical Palliation of Patients with Malignant Pleural Effusion. Analysis of Factors Affecting Survival","volume":"32","author":"Lumachi","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-7819-2-16","article-title":"Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer","volume":"2","author":"Barbetakis","year":"2004","journal-title":"World J. Surg. Oncol."},{"key":"ref_7","first-page":"e20240115","article-title":"Talc slurry versus thoracoscopic talc insufflation for malignant pleural effusion: A systematic review and meta-analysis","volume":"50","author":"Rodrigues","year":"2024","journal-title":"J. Bras. Pneumol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S1111","DOI":"10.21037\/jtd.2017.07.79","article-title":"Diagnosis and management of malignant pleural effusions: State of the art in 2017","volume":"9","author":"Desai","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1440-1843.2007.01154.x","article-title":"Diagnosis and management of malignant pleural effusions","volume":"13","author":"Heffner","year":"2008","journal-title":"Respirology"},{"key":"ref_10","first-page":"22","article-title":"Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients","volume":"57","author":"Ak","year":"2009","journal-title":"Tuberk. Toraks"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.lungcan.2019.09.003","article-title":"Survival in patients with malignant pleural effusion undergoing talc pleurodesis","volume":"137","author":"Hassan","year":"2019","journal-title":"Lung Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"ii29","DOI":"10.1136\/thx.58.suppl_2.ii29","article-title":"BTS guidelines for the management of malignant pleural effusions","volume":"58","author":"Antunes","year":"2003","journal-title":"Thorax"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/pp-2020-0147","article-title":"Survival and pleurodesis outcome in patients with malignant pleural effusion\u2014A systematic review","volume":"6","author":"Hassan","year":"2021","journal-title":"Pleura Peritoneum"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.athoracsur.2019.08.104","article-title":"Talc Pleurodesis: A Medical, Medicolegal, and Socioeconomic Review","volume":"109","author":"Baiu","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.127.3.909","article-title":"Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion","volume":"127","author":"Dresler","year":"2005","journal-title":"Chest"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0003-4975(96)00808-9","article-title":"Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion","volume":"62","author":"Yim","year":"1996","journal-title":"Ann. Thorac. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"335","author":"Altman","year":"2007","journal-title":"BMJ"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1378\/chest.120.1.19","article-title":"Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions","volume":"120","author":"Parulekar","year":"2001","journal-title":"Chest"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/1097-0142(19890915)64:6<1218::AID-CNCR2820640609>3.0.CO;2-V","article-title":"Small bore catheter drainage and sclerotherapy for malignant pleural effusions","volume":"64","author":"Parker","year":"1989","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1148\/radiology.210.1.r99dc04277","article-title":"Malignant pleural effusions: Treatment with small-bore-catheter thoracostomy and talc pleurodesis","volume":"210","author":"Marom","year":"1999","journal-title":"Radiology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR clinical practice guideline","volume":"198","author":"Reddy","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ejcts\/ezy258","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"55","author":"Bibby","year":"2019","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1378\/chest.13-2876","article-title":"Novel use of pleural ultrasound can identify malignant entrapped lung prior to effusion drainage","volume":"146","author":"Salamonsen","year":"2014","journal-title":"Chest"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S2213-2600(21)00353-2","article-title":"Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): An open-label, randomised controlled trial","volume":"10","author":"Psallidas","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.lungcan.2008.02.017","article-title":"Predictors of talc pleurodesis outcome in patients with malignant pleural effusions","volume":"62","author":"Yildirim","year":"2008","journal-title":"Lung Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1378\/chest.08-2448","article-title":"Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?","volume":"136","author":"Terra","year":"2009","journal-title":"Chest"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.110.6.1387","article-title":"Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases","volume":"110","author":"Viallat","year":"1996","journal-title":"Chest"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/1097-0142(19950601)75:11<2688::AID-CNCR2820751108>3.0.CO;2-3","article-title":"Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer","volume":"75","author":"Milanez","year":"1995","journal-title":"Cancer"},{"key":"ref_29","first-page":"1561","article-title":"Short comparison of talc poudrage and tetracycline pleurodesis within patients suffering from malignant pleural effusion","volume":"30","author":"Ashraf","year":"2023","journal-title":"Prof. Med. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s43057-020-00022-3","article-title":"Chemical pleurodesis for malignant pleural effusion: Which agent is perfect?","volume":"28","author":"Saleh","year":"2020","journal-title":"Cardiothorac. Surg."},{"key":"ref_31","first-page":"11","article-title":"Study of Predictors for Successful Pleurodesis in Patients with Malignant Pleural Effusion","volume":"85","author":"Arafa","year":"2020","journal-title":"Med. J. Cairo Univ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ejcts.2006.10.002","article-title":"Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study","volume":"30","author":"Stefani","year":"2006","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/S1807-59322011000200005","article-title":"Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status","volume":"66","author":"Terra","year":"2011","journal-title":"Clinics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1378\/chest.117.1.73","article-title":"Predicting survival in patients with recurrent symptomatic malignant pleural effusions: An assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease","volume":"117","author":"Burrows","year":"2000","journal-title":"Chest"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000356764","article-title":"Prognostic factors in patients presenting with pleural effusion revealing malignancy","volume":"87","author":"Anevlavis","year":"2014","journal-title":"Respiration"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0003-4975(02)03599-3","article-title":"Early and late mortality after pleurodesis for malignant pleural effusion","volume":"74","author":"Bernard","year":"2002","journal-title":"Ann. Thorac. Surg."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/21\/7527\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T04:41:33Z","timestamp":1761367293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/21\/7527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":36,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["jcm14217527"],"URL":"https:\/\/doi.org\/10.3390\/jcm14217527","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}